Embraco

IndustryWeek | April 15, 2020

If nothing else, COVID-19 is demonstrating manufacturers’ ability to take immediate action and embrace a host of new, temporary, operating standards. Not only are these actions protecting the health and safety of employees, they are also helping manufacturer maintain business continuity. For many, this starts with ensuring compliance with local health and safety requirements such as paying close attention to hygiene practices, social distancing, limiting non-essential personnel onsite and ...

businesswire | January 11, 2021

Baxter International Inc, a worldwide pioneer in clean medicine creation and conveyance, today declared that Baxter BioPharma Solutions has gone into a consent to give clean assembling administrations to NVX-CoV2373, Novavax' COVID-19 recombinant nanoparticle immunization applicant with Matrix-M™ adjuvant. Baxter BioPharma Solutions is a head contract fabricating association that works in parenteral (injectable) drugs, including antibodies. The understanding is required to propel busin...

IMEC | February 04, 2021

IMEC launched the Move Ahead Faster Projects for small and mid-sized manufacturers in Illinois to accelerate growth and productivity. IMEC, Illinois affiliate of the U.S Commerce NIST Manufacturing Extension Partnership (MEP) National Network, initiated projects to provide the necessary assessments and technical support. It will not only improve critical drivers of organizational success but will also address the most crucial needs. From this, eligible Illinois manufacturers will also get suppor...

Johnson & Johnson | March 31, 2020

Johnson & Johnson said March 31 that it had arranged a partnership with an arm of the U.S. Department of Health and Human Services to continue development on a vaccine to prevent COVID-19. Janssen Pharmaceutical Companies, a division of Johnson & Johnson, will work with the Biomedical Advanced Research and Development Authority, or BARDA, to fund and quickly test what J&J says is their leading candidate for a coronavirus vaccine. According to Johnson & Johnson, researchers began ...